Resistance exercise modulates lipid plasma profile and cytokine content in the adipose tissue of tumour-bearing rats  by Donatto, F.F. et al.
Cytokine 61 (2013) 426–432Contents lists available at SciVerse ScienceDirect
Cytokine
journal homepage: www.journals .e lsevier .com/cytokineResistance exercise modulates lipid plasma proﬁle and cytokine content
in the adipose tissue of tumour-bearing rats
F.F. Donatto, R.X. Neves, F.O. Rosa, R.G. Camargo, H. Ribeiro, E.M. Matos-Neto, M. Seelaender ⇑
Cancer Metabolism Research Group, Institute of Biomedical Sciences, University of São Paulo, Brazil
a r t i c l e i n f oArticle history:
Received 29 February 2012
Received in revised form 8 September 2012
Accepted 14 October 2012





Cytokines1043-4666/$ - see front matter Crown Copyright  2
http://dx.doi.org/10.1016/j.cyto.2012.10.021
⇑ Corresponding author. Address: Av. Prof. Lineu P
Butanta, São Paulo, Brazil. Fax: +55 011 3091 7402.
E-mail address: seelaend@icb.usp.br (M. Seelaendea b s t r a c t
Cancer cachexia is a multifactorial syndrome characterised by progressive weight loss, frequently accom-
panied by anorexia, sarcopenia, and chronic systemic inﬂammation. The white adipose tissue is markedly
affected by cachexia and contributes to this syndrome throught the secretion of pro-inﬂammatory factors
which reach the adjacent tissues and the circulation. A nonpharmacologic intervention that may attenu-
ate cancer cachexia is chronic physical activity, but the effect of resistance training upon adipose tissue
inﬂammation in cachexia has never been examined. For that purpose we designed a protocol in which
animals were randomly assigned to a control group (CT, n = 7), a Tumour bearing group (TB, n = 7), a
Resistance Trained group (RT, n = 7) and a Resistance Trained tumour bearing group (RTTB, n = 7). Trained
rats climbed a vertical ladder with an extra load attached to the tail, representing 75–90% of total body
mass, 3 times per week, for 8 weeks. In the 6th week of resistance training, tumour cells (3  107 Walker
256 carcinosarcoma) were inoculated in the tumour groups. Body, adipose tissue, muscle and tumour
mass was determined, as well a blood biochemical parameters, and the hormone and cytokine proﬁle
assessed. The glycogen content of the liver and muscle was measured. IL-10, IL-6 and TNF-a protein
expression was evaluated in the mesenteric adipose tissue (MEAT) examined. Resistance training
increased by 9% body weight gain in RTTB (ﬁnal weight 310.8 ± 9.8 g), when compared with TB (ﬁnal
weight 288.3 ± 4.9 g). LDL-c levels were decreased in RTTB (0.28 ± 0.9 mmol/L) by 43% when compared
with TB (0.57 ± 0.1 mmol/L). HDL-c levels were increased in RTTB (1.31 ± 0.12 mmol/L) by 15% in regard
to CT (1.13 ± 0.7 mmol/L) and 22% as compared with TB (1.07 ± 0.07 mmol/L). RTTB testosterone levels
(577 ± 131 ng/mL) were 55% higher when compared with CT (254 ± 41.3 ng/mL) and 63% higher when
compared with TB (221 ± 23.1 ng/mL). Adiponectin levels were augmented in RT (23 lg/mL) by 43%
when compared with TB (11 lg/mL). Protein expression of IL-6 was increased 38% in TB MEAT
(5.95 pg/lg), as compared with CT (3.64 pg/lg) and 50% compared with RTTB (2.91 pg/lg). Similar
results with respect to TNF-a TB (7.18 pg/lg) were observed: 39% and 46%, higher protein expression
in comparison with CT (4.63 pg/lg) and RTTB (3.8 pg/lg), respectively. IL-10 protein expression was
found to be increased in TB (4.4 pg/lg) and RTTB (3.2 pg/lg) 50% and 47%, respectively, in comparison
with CT (1.2 pu/lg). The IL-10/TNF-a ratio was higher in RTTB in relation to all others experimental
groups. The results show a robust effect of resistance exercise training in preventing important symp-
toms of cancer cachexia, thus strongly suggesting it may appear as an alternative to endurance exercise
as a non-pharmacological therapy in the management of this syndrome.
Crown Copyright  2012 Published by Elsevier Ltd. All rights reserved.1. Background biochemical and physiological alterations in response to cachexia,Cachexia is a multifactorial syndrome characterised by progres-
sive weight loss, frequently accompanied by anorexia, sarcopenia,
and chronic systemic inﬂammation [1]. It is today envisaged as a
degenerative chronic inﬂammatory disease, being deeply related
with the increase of pro-inﬂammatory factors, especially tumour
necrosis factor alpha (TNF-a) and interleukin 6 (IL-6) [2]. We have
previously shown [3] than in addition to presenting morphological,012 Published by Elsevier Ltd. All
restes, 1524, CEP 05508-900
r).the white adipose tissue may function as an important contributor
to cachexia-related inﬂammation, as it actively secretes
pro-inﬂammatory factors which reach the adjacent tissues and
the circulation [4].
To the present day, no speciﬁc interventions have proven effec-
tive in preventing or reversing cachexia. Interventions such as
nutritional supplementation and appetite stimulants are only
partially helpful. On the other hand, a most promising nonpharma-
cological intervention that may attenuate cancer cachexia is
chronic physical activity [5]. The literature shows beneﬁts that
range from improvement of overall physical function, to reduce fa-
tigue, and augment of life quality [6], and attenuation of the siderights reserved.
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shown [8–11] that endurance exercise consistently ameliorates ca-
chexia-related inﬂammation in a rodent model, presenting a sys-
temic effect that is also conspicuous in regard to the adipose tissue.
Nevertheless, endurance exercise training may not be well ac-
cepted by all patients, as it demands more time than strength exer-
cise sessions to be performed. Indeed, some reports suggest that
resistance exercise may improve aspects of cachexia [5]. To our
knowledge this is the ﬁrst report to show the robust effects of
resistance exercise training upon adipose tissue inﬂammation in
cachexia, along with amelioration of many other symptoms of
the syndrome.2. Methods and materials
2.1. Animals
The investigation conformed to the Guide for the care and use of
laboratory animals published by the US National Institute of Health
(NIH Publication No. 85–23, revised 1996) and was approved by
the Committee of Ethics in Animal Experimentation of the Institute
of Biomedical Sciences, University of São Paulo. Wistar male rats
(70 days old), from the Animal House of the Biological Science
Building, University of São Paulo, were maintained under con-
trolled temperature (23 C), humidity (55% ± 10%), and a 12-h
light/12-h dark cycle. The rats had free access to water and to a
standard commercial chow (Nutrilab-CR1; Nuvital Nutrients Ltda)
containing the following: carbohydrate (660 g/kg), protein
(230 g/kg), fat (40 g/kg), ﬁbre (60 g/kg), and vitamins plus minerals
(10 g/kg). All animals were adapted to the laboratory environment
for 1 week, before engaging the training program. Rats were
randomly assigned to four experimental groups: control (C)
(n = 7), tumour-bearing (TB) (n = 7), Resistance Trained (RT)
(n = 7) and tumour-bearing RT (RTTB) (n = 7).
2.2. Resistance exercise training
The resistance training protocol was adapted from Hornberger
and Farrar [12], During the 8 weeks of resistance training, climbing
sessions were performed once every 3 days. Initially, the rats were
adapted to the resistance training protocol, which required that the
animals climbed a vertical ladder (1.1  0.18 m, 2-cm grid, 80 in-
cline), with weights secured to their tails, as described below. The
load apparatus was secured to the tail by wrapping the proximal
portion of the tail with a self-adhesive foam strip. A Velcro strap
was wrapped around the foam strip and fastened. With the load
apparatus secured to the tail, the rats were placed at the bottom
of the ladder and familiarised with climbing. The initial climb con-
sisted of carrying a load that was 75% of the animal’s body mass.
After this, an additional 30 g weight was added until a load was
reached with which the rat could not climb the entire length of
the ladder. Failure was determined when the animal could not pro-
gress up the ladder after 3 successive stimuli to the tail. The high-
est load successfully carried the entire length of the ladder was
considered the rat’s maximal carrying capacity for that training
session. Training sessions were 3–5 ladder climbs with 75%, 90%,
and 100% of the rat’s previous maximal carrying capacity, deter-
mined earlier. During subsequent ladder climbs, an additional
30 g load was added until a new maximal carrying capacity was
determined.
2.3. Tumour injection
Walker 256 carcinosarcoma cells were inoculated (subcutane-
ous injection into the right ﬂank as a sterile suspension of 3  107cells) in groups TB and RTTB, in the beginning of the 6th week of
the training protocol. Fifteen days after tumour inoculation
(8 weeks after starting the protocol) the animals were killed by
decapitation, 48 h after the last exercise session, as to avoid the
acute effects of exercise. Body weight and caloric consumption
were measured throughout the experimental period, and tumour
weight was determined after euthanasia. Blood was collected and
serum obtained for the measurement of the different parameters.
2.4. Determination of muscle and hepatic glycogen content
Muscle samples were digested in 30% KOH at 100 C and glyco-
gen was precipitated with ethanol, between each precipitation the
samples were centrifuged at 3000 rpm for 15 min. The precipitated
glycogen was submitted to acid hydrolysis in the presence of phe-
nol. The values expressed in mg/100 mg of wet weight, using the
method described by Siu [13].
2.5. Plasma proﬁle determination
All reagents and chemicals adopted were of analitical grade.
Serum total cholesterol, triacylglycerol, glucose, lactate dehydro-
genase, creatinine and high-density lipoprotein cholesterol were
determined using Labtest Blood samples from animals fasted
for 12 h, were collected after euthanasia. The samples were or
not anticoagulated with EDTA (1 mg/mL) and centrifuged at
2.500g at 4 C for 15 min to obtain plasma and serum and the
tests were carried out in conformation with laboratory kit instruc-
tions. VLDL-cholesterol was calculated using the formula TG/
2.2 mmol/L. Low density lipoprotein (LDL) cholesterol was deter-
mined by differential substraction of the sum of the cholesterol
fractions from the total cholesterol. Liver TAG content was ex-
tracted with chloroform: methanol 2:1 (v/v) and measured in
accordance with the method described by Folch [14].
2.6. Hormone and cytokine plasma levels
The samples were anticoagulated with EDTA (1 mg/mL) and
centrifuged at 2.500g at 4 C for 15 min to obtain plasma for deter-
mination of testosterone, leptin and adiponectin with commercial
kits and expressed in ng/mL. For leptin and adiponectin, the kits
were obtained from Millipore Corp. Bedford, MA, USA and for tes-
tosterone, from Assay Designs, Inc., Ann Arbor, MI, USA.
2.7. Muscle lactate dehydrogenase activity
To characterise the metabolic effect of resistance exercise, lac-
tate dehydrogenase activity, an index of glycolytic capacity, was
determined in the gastrocnemius of the rats. Tissue samples were
homogenised at 0 C in a volume of 1 mL of 100 mM KPO4 buffer, so
that a 1:20 (wt/vol) homogenate was obtained. LDH activity was
measured according to the spectrophotometric method described
by Fritz [15]. All assays were linear with respect to time and dilu-
tion, and each sample was analysed in duplicate.
2.8. Muscle protein content
Gastrocnemius protein concentration was determined by Brad-
ford assay (Bio-Rad, Hercules, CA), with bovine serum albumin as a
reference.
2.9. Immunoassays for cytokines in the adipose tissue
Adipose tissue samples were carefully rinsed in ice-cold 0.9%
NaCl to remove any blood contaminants and snap frozen in
liquid nitrogen and stored at 80 C. Frozen tissue (0.1–0.3 g) was
Fig. 1. RM evolution along the exercise protocol. Values are mean ± SD; RM
(repetition maximum); RT (resistance training) and RTTB (resistance training
tumour-bearing). Values that are signiﬁcantly different by test t. p < 0.05 compared
with RT.
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deoxycholate, 6.25 mM sodium phosphate, and 1 mM ethylenedia-
mine tetraacetic acid at pH 7.4) containing 10 Lg/mL of protease
inhibitor cocktail (Sigma–Aldrich, St. Louis, Missouri). Homoge-
nates were centrifuged at 12,000g for 10 min at 4 C, the superna-
tant was saved, and protein concentration was determined by
Bradford assay (Bio-Rad, Hercules, CA) with bovine serum albumin
as a reference. For the TNF-a (DY510), IL-6 (DY506) and IL-10
(DY522) assays, sensitivity was found to be 5.0 pg/mL in the range
of 31.2–2.000 pg/mL. Assay sensitivity for IL-10 was 10 pg/mL in
the range from 31.2 to 2.000 pg/mL. All samples were run as dupli-
cates, and the mean value was reported.
3. Statistical treatment
Data are presented as means ± standard deviation (SD). Statisti-
cal analysis was performed with Student’s T test for resistance pro-
tocol progress and 2-way analysis of variance (2-way ANOVA) with
exercise and tumour as factors. All variables presented normal dis-
tribution and homoscedasticity, when t difference was found to be
signiﬁcant, Tukey’s post hoc test was adopted. A signiﬁcance level
of p 6 0.05 was employed for all comparisons. Statistical analysis
was carried out with GraphPad prism software, version 5.0 (Graph-
Pad Software, San Diego, CA).
4. Results
4.1. Tissue weigtht
Table 1 illustrates the values of body weight before and after the
training period, as well as the absolute retroperitoneal adipose tis-
sue (RPAT), mesenteric adipose tissue (MEAT), epididymal adipose
tissue (EPAT), and gastrocnemius weights. Resistance training in-
creased body weight gain of RTTB, when compared with TB (9%
p < 0.048), along with higher absolute gastrocnemius muscle
weight (26% p < 0.027). RPAT showed statistical difference in TB
and RTTB when compared with Control. (30%; p < 0.002 and 56%
p < 0.001), showing that both the presence of the tumour and the
exercise protocol inﬂuence this parameter. Tumour mass was de-
creased after exercise, yet the difference did not reach statistical
signiﬁcance.
4.2. Resistance training progress chart
Fig. 1 illustrates the progress of resistance training overload
during the experimental period. A separate RT group was run to
compare the maximal repetition (1-RM) evolution in the absenceTable 1
Body weight, adipose tissue and gastrocnemius weight.
Experimental groups CT TB RT RTTB
Initial body weight (g) 209.3 ± 3.2 216.5 ± 4.9 208.6 ± 7.9 211.2 ± 2.8
Final body weight (g) 335.6 ± 3.4 288.3 ± 4.9a 348.5 ± 10.9b 310.8 ± 9.8b
Final tumour weight (g) – 32 ± 0.8 – 19,6 ± 0.5
Absolute EPAT (g) 3.6 ± 0.3 3.28 ± 0.7 2.96 ± 0.9 3.06 ± 0.3
Absolute MEAT (g) 1.74 ± 0.3 2.19 ± 0.4 1.89 ± 0.7 2.09 ± 0.4
Absolute RPAT (g) 3.16 ± 1.2 2.22 ± 0.2a 2.14 ± 0.4a 2.02 ± 0.7a
Absolute
gastrocnemius (g)
2.65 ± 0.3 1.72 ± 0.1a 2.75 ± 0.4ab 2.30 ± 0.2b
Values are mean ± SD; initial and ﬁnal body mass; absolute weight of the adipose
tissues: Epididymal adipose tissue (EPAT), Mesenteric adipose tissue (MEAT) and
Retroperitoneal adipose tissue (RPAT); tumour and gastrocnemius. CT (control), TB
(tumour-bearing), RT (resistance training) and RTTB (resistance training tumour-
bearing). Values that are signiﬁcantly different by two-way ANOVA are indicated.
a p < 0.05 compared with control.
b p < 0.05 compared with TB.of the tumour. After tumour inoculation induced a decrease in total
work performed (initial 6th week). RTTB presented reduced perfor-
mance by 10% (p < 0.05), when compared with RT in the 6th, 7th
and 8th weeks of the exercise protocol.4.3. Plasma biochemistry
The analysis of the plasma (Table 2) demonstrates a reduction
of glycaemia in RTTB, when compared with CT (21%; p < 0.006)
and TB (20%; p < 0.008). With respect to TAG, TB levels were 29%
(p < 0.02) higher then CT’s and no signiﬁcant difference was de-
tected regarding RTTB. The Lipoprotein proﬁle presented heteroge-
neous results: in relation to VLDL-c, there was an increase of 30%
(p < 0.03) in TB compared with CT. The parameter was not different
among RTTB, CT and TB. LDL-c levels were decreased in RTTB by
43% (p < 0.029), when compared with TB, while no difference was
found for CT. HDL-c levels were increased in RTTB by 15%
(p < 0.049) compared with CT and 22% (p < 0.005), as compared
with TB. Creatinine and LDH activity did not show signiﬁcant var-
iation among the experimental groups. With respect to hormones,
testosterone was shown to be 55% (p < 0.042) and 63% (p < 0.03)
higher, in RTTB compared with CT and TB, respectively.Table 2
Plasma biochemical proﬁle of experimental groups.
Parameters CT TB RT RTTTB
Glucose (mmol/L) 4.5 ± 0.2 4.6 ± 0.01 4.02 ± 0.2 3.8 ± 0.3a,b
Cholesterol (mmol/L) 2.49 ± 0.7 2.61 ± 0.4 2.37 ± 0.03 2.57 ± 0.2
TAG (mmol/L) 1.11 ± 0.07 1.44 ± 0.1a 1.03 ± 0.02a,b 1.24 ± 0.2
VLDL-c (mmol/L) 0.49 ± 0.03 0.64 ± 0.01a 0.46 ± 0.01b 0.55 ± 0.13
LDL-c (mmol/L) 0.49 ± 0.6 0.57 ± 0.1 0.24 ± 0.7a,b 0.28 ± 0.9b
HDL-c (mmol/L) 1.13 ± 0.7 1.07 ± 0.07 1.33 ± 0.13a,b 1.31 ± 0.12a,b
Creatinine (lmol/L) 18.96 ± 6.8 14.2 ± 3.2 17.85 ± 2.5 16.88 ± 2.9
Testosterone (ng/mL) 254 ± 41.3 221 ± 23.1 734 ± 88.2a,b 577 ± 131a,b
Values are mean ± SD; serum level: Glucose, Cholesterol total, TAG (triacylglycerol),
VLDL-c (Very low-density lipoprotein), LDL-c (Low-density lipoprotein), HDL-c
(High-density lipoprotein), Creatinine and testosterone; CT (control), TB (tumour-
bearing), RT (resistance training) and RTTB (resistance training tumour-bearing).
Values that are signiﬁcantly different by two-way ANOVA are indicated by two-way
ANOVA.
a p < 0.05 compared with control.
b p < 0.05 compared with TB.
Table 3
Gastrocnemius analysis.
Parameters CT TB RT RTTTB
Protein (lg/lL) 4.7 ± 0.1 4.5 ± 0.08 5.9 ± 0.03b 5.1 ± 0.3
Glycogen (mg/g) 3.8 ± 0.29 3.4 ± 0.33 5.3 ± 0.45b 4.8 ± 0.12b
IL-6 (pg/lg) 0.03 ± 0.02 0.08 ± 0.01 0.10 ± 0.01a 0.12 ± 0.03a
LDH (U/mg) 6.79 ± 0.9 7.03 ± 0.3 9.45 ± 0.9a,b 9.35 ± 0.6a
Values are mean ± SD; gastrocnemius proﬁle: total protein, glycogen, IL-6 (inter-
leukin-6) and LDH (lactate dehydrogenase); CT (control), TB (tumour-bearing), RT
(resistance training) and RTTB (resistance training tumour-bearing). Values that are
signiﬁcantly different by two-way ANOVA are indicated.
a p < 0.05 compared with control.
b p < 0.05 compared with TB.
Fig. 3. Adiponectin plasma levels. Values are mean ± SD; CT (control), TB (tumour-
bearing), RT (resistance training) and RTTB (resistance training tumour-bearing).
Values that are signiﬁcantly different by two-way ANOVA are indicated. b = p < 0.05
compared with TB.
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Gastrocnemius muscle protein content (Table 3) showed a sta-
tistical difference in RT, as compared with TB. IL-6 in RTTB was 90%
higher (p < 0.002) when compared with CT and 20% higher
(p < 0.043) compared with TB. In the gastrocnemius, glycogen con-
tent of RT and RTTB showed statistical difference when compared
with TB. The activity of LDH in RTTB was increased 27% (p < 0.044)
in relation to CT and showed no difference in comparison with TB.
4.5. Liver biochemistry
Glycogen content (Table 4) in the liver showed no differences
among the experimental groups. Liver TAG content was lower in
RT and RTTB, when compared with TB.
4.5.1. Plasma adipocytokine levels
In the Fig. 2, leptin levels were decreased in RTTB compared
with CT (p < 0.003; 72%) and TB (69%; p < 0.008). Adiponectin con-Table 4
Glycogen and tryacilglycerol content in the liver.
Parameters CT TB RT RTTTB
Glycogen (mg/g) 2.2 ± 0.02 1.8 ± 0.08 2.6 ± 0.1 2.3 ± 0.2
TAG (mg/
100 mg liver)
52.9 ± 1.96 104.6 ± 22.11a,b 45.5 ± 9.93b 70.4 ± 9.01a,b
Values are mean ± SD; liver proﬁle: glycogen and TAG (triacylglycerol); CT (control),
TB (tumour-bearing), RT (resistance training) and RTTB (resistance training tumour-
bearing). Values that are signiﬁcantly different by two-way ANOVA are indicated.
a p < 0.05 compared with control.
b p < 0.05 compared with TB.
Fig. 2. Leptin plasma levels. Values are mean ± SD; CT (control), TB (tumour-
bearing), RT (resistance training) and RTTB (resistance training tumour-bearing).
Values that are signiﬁcantly different by two-way ANOVA are indicated a = p < 0.05
compared with control and b = p < 0.05 compared with TB.centration (Fig. 3) was higher in RT and RTTB (43% and 39%), yet
only for RT (p < 0.001) statistical difference was found, when com-
paring with TB.
4.6. Citokines in the mesenteric adipose tissue
The local tissue concentration of TNF-a, IL-6 and IL-10 was as-
sessed by enzyme linked immuno sorbent assay (ELISA). TNF-a
protein expression (Fig. 4) was higher 39% (p < 0.04) in comparison
with CT and 46% (p < 0.035) higher, compared with RTTB. IL-6 in
MEAT was higher in TB-38% (p < 0.04), when compared with CT
and 50% (p < 0.03) when compared with RTTB (Fig. 5). The IL-10
expression (Fig. 6) was increased in TB and RTTB 50% and 47%,
respectively when compared with CT. The IL-10/TNF-a ratio
(Fig. 7) was higher in RTTB when compared with all other experi-
mental groups5. Discussion
Cancer cachexia afﬂicts around 80% of all hospitalised cancer
patients and although directly causing up to 40% of all cancer
deaths and markedly compromising cancer therapy outcome, has
not so far, met a satisfactory treatment. Nutritional intervention
has proven to improve some aspects of the syndrome, but still no
nutrient or combination of nutrients is efﬁcient in counteractingFig. 4. TNF-a levels in the mesenteric adipose tissue (MEAT). Values are mean ± SD;
CT (control), TB (tumour-bearing), RT (resistance training) and RTTB (resistance
training tumour-bearing). Values that are signiﬁcantly different by two-way
ANOVA are indicated. b = p < 0.05 compared with TB.
Fig. 5. IL-6 levels in the mesenteric adipose tissue (MEAT). Values are mean ± SD;
CT (control), TB (tumour-bearing), RT (resistance training) and RTTB (resistance
training tumour-bearing). Values that are signiﬁcantly different by two-way
ANOVA are indicated by two-way ANOVA b = p < 0.05 compared with TB.
Fig. 6. IL-10 levels in the mesenteric adipose tissue (MEAT). CT (control), TB
(tumour-bearing), RT (resistance training) and RTTB (resistance training tumour-
bearing). Values that are signiﬁcantly different by two-way ANOVA are indicated
a = p < 0.05 compared with control, b = p < 0.05 compared with TB and c = p < 0.05
compared with RT.
Fig. 7. IL-10/TNF-a ratio in the mesenteric adipose tissue. CT (control), TB (tumour-
bearing), RT (resistance training) and RTTB (resistance training tumour-bearing).
Values that are signiﬁcantly different by two-way ANOVA are indicated a = p < 0.05
compared with control, b = p < 0.05 compared with TB and c = p < 0.05 compared
with RT.
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the other hand, may elicit more comprehensive results, yet is asso-
ciated with deleterious side effects.We have in the last years [8–11] addressed the potential of
chronic physical exercise as a low cost, safe adjuvant therapy in ca-
chexia, which is able to induce cachexia-attenuating effects in a
systemic manner, thus affecting every and all compartments in
the body. In particular, these previous studies clearly demonstrate
the capacity of regular endurance exercise to reduce cachexia-
related systemic inﬂammation. However, some patients may ﬁnd
endurance sessions too long to be performed on a daily basis, espe-
cially considering that cancer treatment is per se already time-
consuming. Bearing this in mind we sought to examine whether
a resistance exercise protocol would induce similar results, thus
appearing as a less time-consuming, indoor alternative to submax-
imal intensity, long duration exercise. Resistance exercise has been
associated with positive effects on the cardiovascular system, lean
body mass and reported to decrease the risk of metabolic disorders
[16].
In order to compare the two different exercise strategies, we
adopted the same animal model of cachexia employed in our pre-
vious studies focusing on endurance exercise, the Walker 256 car-
cinosarcoma, known to induce most of the symptoms associated
with human cachexia [17].
Resistance training exercise is known to promote physiological
changes that may serve as markers of its effects, such as increase in
muscle lactate dehydrogenase activity (the enzyme that that con-
verts pyruvate to lactate in the glycolytic process [18] and aug-
mented testosterone circulating levels [19]. The adopted
resistance protocol was efﬁcient in inducing such changes, as in
RTTB increased LDH activity and testosterone levels were found,
when compared with TB.
In a recent report, Prestes et al. [20] analysed the effect of RT
upon muscle glycogen content in rats subjected to ovariectomy,
having demonstrated a glycogen-sparing effect in the muscle. In
our study model, a reduction in total muscle weight and in the
amount of glycogen and the gastrocnemius was found for TB, but
not for RTTB, pointing out to a positive effect of resistance exercise
against sarcopenia and muscle glycogen depletion associated with
cachexia.
Plasma lipid proﬁle was also examined, because cachexia and
resistance exercise exert opposite effects on these parameters.
Hyperlipidaemia is a hallmark of the paraneoplastic syndrome,
and serves as a means for its diagnosis [21]. This symptom is a re-
ﬂex from the combination of diminished lipoprotein lipase (LPL)
activity in white adipose tissue and muscle of tumour-bearing ani-
mals [22] increased free fatty acid release from adipose depots [23]
and impaired hepatic lipoprotein metabolism [24]. Resistance
exercise exerts, on another hand, opposite effects, decreasing cir-
culating TAG and modulating lipoprotein metabolism [25].
We demonstrated that plasma glucose, TAG, HDL-c, LDL-c and
VLDL-c were affected by 8 week of resistance training in tumour-
bearing animals, who showed an improved lipid proﬁle, as
compared with the sedentary counterparts (TBs). Additionally,
the protocol was able to reduce cachexia-related steatosis-liver
lipid content was decreased in RT and RTTB, by 58% and 33%, respec-
tively, in comparison with the control groups. In a recent study
adopting the same resistance exercise protocol, Domingos et al.
[26] demonstrated a down regulation of hepatic genes involved
in the development of steatosis in rats submitted to ovariectomy.
The white adipose tissue is markedly affected by cachexia, but
in addition, may contribute consistently to systemic inﬂammation
[27]. Indeed this tissue is currently envisaged as a major endocrine
organ, expressing a variety of pro and anti-inﬂammatory factors
and hormones.
Amongst the latter, leptin communicates the status of energy
reserves of the organism to the brain, thereby regulating feed-
ing, substrate utilization, energy balance, and the endocrine,
immune systems [28]. In advanced cancer patients, serum leptin
F.F. Donatto et al. / Cytokine 61 (2013) 426–432 431concentrations may be depressed as a consequence of reduced
body fat mass [29] and rodents display the same symptom [3].
We report a marked decrease in the circulating levels of leptin as
a consequence of the exercise protocol, (p < 0.003; 72% when com-
pared with CT) and (69%; p < 0.008, in relation to TB), however this
effect bears no direct relationship with diminished adipose tissue
mass, as we found no difference among the experimental groups.
Unfortunately, we did not measure this hormone protein expres-
sion in the adipose pads. Exercise elicits controversial effects on
leptin secretion, depending on exercise type and duration [30].
We report for the ﬁrst time, that resistance exercise has an anti-
inﬂammatory effect upon the adipose tissue in cachexia, in a man-
ner that does not greatly differ from that of endurance exercise.
Our previous studies show that the anti-inﬂammatory effect of
exercise is, as expected, more evident under the presence of
pathological conditions, such as heart failure [31], cancer cachexia
[8–11,32] and malnourishment [33]. Similarly, we found a more
pronounced exercise-related shift towards an anti-inﬂammatory
proﬁle in the tumour-bearing animals.
TNF-a, a potent inﬂammatory cytokine, presents greatly in-
creased concentration during cachexia and in addition to modulat-
ing adipose tissue lipolysis in this setting, is actively secreted by
the white adipose tissue [3,34]. Therefore, we chose to examine
adipose tissue protein expression of the pro-inﬂammatory cyto-
kine TNF-a and of the anti-inﬂammatory cytokine IL-10, since plas-
ma concentration of these cytokines is known to change under the
stimulus of both physical exercise [35,36] and cachexia [37] and it
is well established that the adipose tissue is capable of synthesis-
ing these factors [38], hence very likely contributing to circulating
levels. Our studies with endurance exercise have shown a potent
anti-inﬂammatory effect of physical activity [8–11]. We here in re-
port a consistent change in the ratio between TNF-a and IL-10,
indicating a clear shift, induced by resistance exercise training,
favouring an anti-inﬂammatory milieu in the mesenteric pad. This
ratio has been adopted by us [9] and others [37] as a means of
assessing the degree of inﬂammation.
Another evidence corroborating the assumption that resistance
exercise training has an anti-inﬂammatory effect is the fact that
skeletal muscle IL-6 expression was increased by the protocol.
Pedersen [39] showed that regular exercise modulates anti-
inﬂammatory myokine expression. IL-6 has a negative feedback
role in which it acts in the down regulation of cytokines stimulat-
ing inﬂammation at tissue level (e.g. inducing suppression of
TNF-a expression) and thereby offering protection against exacer-
bation of inﬂammation. After 8 weeks of resistance training we
found an increased IL-6 protein expression in the gastrocnemius
of RTTB when compared with TB. When assessing IL-6 and TNF-a
protein expression in the MEAT, the results were the opposite, with
TB showing higher protein expression than RTTB in MEAT pad.
Adipose tissue-derived IL-6, contrary to that secreted by the
muscle, exerts a pro-inﬂammatory action [40].
Cachexia associated with cancer exhibits different effects on li-
pid metabolism in regard to the anatomical localisation of the fat
depot [41]. These changes in lipid metabolism are associated with
increased inﬂammation in the fat depots. Rosa Neto and colleagues
[42] demonstrated that acute exhaustive exercise increases IL-6
protein content to a broader extent in RPAT as compared with mes-
enteric white adipose tissue (MEAT). These results add to the con-
cept that different fat pads present a heterogeneous response to
the same stimulus. In fact, as previously reported, RPAT hor-
mone-sensitive lipase activity increases with exercise, while no ef-
fect was observed in MEAT [43]. In the present study, we show that
MEAT is the main depot on which the effect of resistance exercise
training is present.Adiponectin is a cytokine produced and secreted exclusively by
the adipose tissue. Decreased adiponectin levels are associated
with the induction of metabolic syndrome, insulin resistance, and
increased plasma lipid levels and circulating pro-inﬂammatory
cytokines such as TNF-a [44–48]. In resistance exercise training
positively modulated the concentration of plasma adiponectin.
Finally, the protocol was able to prevent cachexia-related steato-
sis. There is growing evidence that resistance training stimulates li-
pid oxidation in the liver and in the adipose tissue and it is tempting
to speculate that resistance training could induce a decrease in the
expression of transcription factors related to lipogenesis, improving
liver fat oxidation and consequently reducing liver lipid content [49].
Taken together, the results reﬂect a potent effect of resistance
exercise training in the prevention of systemic consequences of
cancer cachexia, with a conspicuous down modulation of chronic
inﬂammation, in a fashion that is similar to that induced by endur-
ance exercise. Therefore we may suggest that this may be an
advantageous low cost, low risk, time sparing strategy in the adju-
vant treatment of the syndrome. This becomes of particular inter-
est when the classiﬁcation of cachexia into pre-cachexia, cachexia
and refractory cachexia [50] is considered, since we might assume
that patients presenting the early stages of the disease may beneﬁt
from engaging into a regular resistance exercise programme. It is
also possible to suggest that the reported quality of life improve-
ment in cancer patients who perform resistance exercise may be
associated with its capacity to counteract systemic inﬂammation
as shown by this study.
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